))
Unlocking the Secrets of Healthcare Disruption with Tomas Studenik and Evegeny Shvarov: Venture Vitals, Your Gateway to Global Startup Success Are you a daring entrepreneur seeking to revolutionize the healthcare industry? Look no further than Venture Vitals, the essential lifeline for visionary startups and investors in the realm of health tech. Brought to you by Tomas Studenik and Evgeny Shvarov, the founders of the renowned Caelestinus Incubator, this podcast is your direct connection to ...
…
continue reading
In their fourth epizode, Venture Vitals’ Tomas Studenik and Evgeny Shvarov invited a precision medicine startup CEO, Mike, to be their guest and respondent for over 45 minutes of all-about-building-a-global-med-tech-unicorn. Mike Zack, MD, PhD, MPH, is the Co-Founder and CEO of PGxAI (https://pgx.ai), a key opinion leader (KOL) in pharmacogenomics …
…
continue reading
In the latest episode of Venture Vitals, Tomas Studenik and Evgeny Shvarov sit down with Antxon Caballero, CEO of Heuristik, to explore the complex landscape of doing business with hospitals in Spain, EU as well as U.S. From navigating identity verification issues to managing high-damage claims, Antxon shares valuable insights on mitigating risks i…
…
continue reading
1
2: Episode II: Marco Benitez and Jonas Dücker, ROOK
52:49
52:49
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
52:49
In this exciting episode of Venture Vitals, Tomas and Evgeny sit down with Marco and Jonas, the CEO and COO of ROOK, to explore the intricacies of launching and growing a healthtech startup in the US. Tune in to hear: • Marco and Jonas share their personal journeys into health tech. • The inspiration behind starting ROOK and the innovative idea dri…
…
continue reading
1
1: Episode I: Allan Gobbs, ATEM Capital
1:07:02
1:07:02
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:07:02
In this compelling episode of Venture Vitals, Tomas and Evgeny sit down with Allan Gobbs, Managing Partner at NY-based Life Sciences venture firm ATEM Capital, to uncover the secrets of health tech investment success. Join us as Allan shares his extraordinary journey from managing a $760M partnership to celebrating multiple NASDAQ listings and high…
…
continue reading
